Publications

2020

  1. Jorbenadze A, Shaburishvili N, Mirro M, Zuber M, Erne P, Shaburishvili T. First-in-Human VisONE Heart Failure Study: Asymptomatic Diaphragmatic Stimulation for Chronic Heart Failure with Reduced Ejection Fraction – Case Report. JACC, Vol 75, Issue 11 Supplement 1, March 2020.

  2. Zuber M, Young R, McConnachie A, Shaburishvili T, Rudenko K, Demyanchuk V, Jorbenadze A, Buriak R, Todurov B, Mirro M, Nikitin N, Erne P, Cleland J. First in Human VisONE Heart Failure Study: Asymptomatic Diaphragmatic Stimulation for Chronic Heart Failure : One Month Results. J Cardiac Failure. 2019, 25(8): S183. (presented at the HFSA conference, 2019, Philadelphia, Pennsylvania).

2019

  1. Zuber M, Young R, Shaburishvili T, Rudenko K, Demyanchuk V, Jorbenadze A, Buriak R, Todurov B, Mirro M, Nikitin N, Erne P, McConnachie A , Cleland J. First-in-Human VisONE Heart Failure Study Implant Experience and Study Design: Asymptomatic Diaphragmatic Stimulation for Chronic Heart Failure. Eur J of HF. 2019; 21 (suppl. S1): P523-524. (presented at the ESC HF conference, 2019, Athens, Greece).

2018

  1. Saccocci M, Luciani M, Cesarovic N, Lipiski M, Kuwata S, Guidotti A, Regar E, Zuber M, Maisano F. Diaphragmatic Stimulation Effects on Cardiovascular Function – a New Acute Porcine Heart Failure Model. Cardiovascular Medicine. 2018; 21(05): P32. (presented at the Swiss Society of Cardiology conference 2018, Basel, Switzerland).

2017

  1. Beeler R, Schoenenberger A, Zuber M, Bauer P, Erne S, Schlaepfer R, Erne P. Sustained Improvements to Ventricular Function due to Asymptomatic Diaphragmatic Function. J Cardiac Failure. 2017; 23(8):S120. (presented at HFSA 2017, Dallas, Texas)

  2. Bauer P, Snell J, Wheeler T, Chinchoy E, Mirro M. Animal Instrumentation Model of Diaphragmatic Stimulation Effects on Cardiovascular Function. J Cardiac Failure. 2017; 23(8):S120. (presented at HFSA 2017, Dallas, Texas).

  3. Beeler R, Schoenenberger A, Zuber M, Bauer P, Erne S, Schlaepfer R, Erne P. Stability of Asymptomatic Diaphragmatic Stimulation Thresholds after 1 Year : Results of the Epiphrenic II Pilot. J Cardiac Failure. 2017; 23(8):S120. (presented at HFSA 2017, Dallas, Texas).

  4. Beeler R, Schoenenberger A, Zuber M, Bauer P, Bergner M, Erne S, Schlaepfer R, Erne P. Sustained improvements to ventricular function due to asymptomatic diaphragmatic function. EJH 2017; 38 (suppl 1), ehx504.P3374. (presented at ESC 2017, Barcelona, Spain).

2014
  1. Beeler R, Schoenenberger AW, Bauer P, Kobza R, Bergner M, Mueller X, Schlaepfer R, Zuber M, Erne S, Erne P. Improvement of Cardiac Function with Device-based Diaphragmatic Stimulation in Chronic Heart Failure Patients. Eur J Heart Failure. 2014; 16(3): 342-9.

2010
  1. Zuber M, Roos M, Kobza, R, Toggweiler S, Meier R, Erne P. Detection and Hemodynamic Significance of Cardiac Pacemaker-Induced Phrenic Nerve Stimulation. Congestive Heart Failure. 2010; 16(4):147-152.

2009
  1. Roos M, Kobza R, Jamshidi P, Bauer P, Resink T, Schlaepfer R, Stulz P, Zuber M, Erne P. Improved Cardiac Performance Through Pacing-induced Diaphragmatic Stimulation: A Novel Electrophysiological Approach in Heart Failure Management?. Europace. 2009; 11:191-199.

2007
  1. Toggweiler S, Kobza R, Roos M, Erne P. Visualizing Pacemaker-Induced Phrenic Nerve Stimulation with Acoustic Cardiography. Pacing and Clinical Electrophysiology. 2007; Jun; Vol. 30:806.